Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score‐matched analysis
Gang Ma, HaiXia Jiang, XiYang Zhang, Tao Zhu – 6 August 2015
Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C
Soichiro Shibata, Takeji Umemura, Michiharu Komatsu, Eiji Tanaka – 6 August 2015
Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012
Henry Roberts, Deanna Kruszon‐Moran, Kathleen N. Ly, Elizabeth Hughes, Kashif Iqbal, Ruth B. Jiles, Scott D. Holmberg – 6 August 2015 – The number of persons with chronic hepatitis B virus (HBV) infection in the United States is affected by diminishing numbers of young persons who are susceptible because of universal infant vaccination since 1991, offset by numbers of HBV‐infected persons migrating to the United States from endemic countries.
Should age matter? A new proposal for liver transplantation allocation
Lisa B. VanWagner, Anton I. Skaro – 6 August 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1
Paula M. Perin, Sibylle Haid, Richard J.P. Brown, Juliane Doerrbecker, Kai Schulze, Carsten Zeilinger, Markus von Schaewen, Brigitte Heller, Koen Vercauteren, Eva Luxenburger, Yasmine M. Baktash, Florian W.R. Vondran, Sietkse Speerstra, Abdullah Awadh, Furkat Mukhtarov, Luis M. Schang, Andreas Kirschning, Rolf Müller, Carlos A. Guzman, Lars Kaderali, Glenn Randall, Philip Meuleman, Alexander Ploss, Thomas Pietschmann – 6 August 2015 – To explore mechanisms of hepatitis C viral (HCV) replication we screened a compound library including licensed drugs.
Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy
Kyu Sik Jung, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Kwang‐Hyub Han – 6 August 2015 – Several risk prediction models have been created to predict hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) occurrence, with promising results. However, their prognostic performances need to be validated in the era of antiviral therapy. From 2006 to 2011, patients with chronic HBV infection were recruited and those with a history of HCC or hepatic decompensation were excluded.
Genetic susceptibility to hepatitis E viral infection: An enigmatic virus gives up a secret
Ivo Ditah, Michael Charlton – 6 August 2015
Clinical human hepatocyte transplantation: Current status and challenges
Anil Dhawan – 6 August 2015
Reply
Yohei Fujii, Yoshihito Uchida, Satoshi Mochida – 6 August 2015
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Hui Wang, Souhayla El Maadidi, Janett Fischer, Elena Grabski, Sabine Dickhöfer, Sascha Klimosch, Sinead M. Flannery, Angela Filomena, Olaf‐Oliver Wolz, Nicole Schneiderhan‐Marra, Markus W. Löffler, Manfred Wiese, Tica Pichulik, Beat Müllhaupt, David Semela, Jean‐François Dufour, Pierre‐Yves Bochud, Andrew G. Bowie, Ulrich Kalinke, Thomas Berg, Alexander N.R.